drugset / Trial / NCT02379858

Gastrointestinal Tract Recovery in Patients Undergoing Open Ventral Hernia Repair

NCT02379858

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether Alvimopan (Entereg) in ventral hernia surgery patients is associated with accelerated gastrointestinal recovery and reduced length of hospital stay compared to placebo controls.

Timeline

Start
2015-07
Primary completion
2018-05-31
Completion
2018-05-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Alvimopan Small molecule 12 mg Oral

Indications

No indication recorded.